Larry Mathis Financial Planning’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
Other funds holding TAK
Larry Mathis Financial Planning's TAK Position: Q3 2026 in Review
Larry Mathis Financial Planning reduced its Takeda Pharmaceutical (TAK) stake by 5.4% in Q3 2026, selling an estimated $13.9K and leaving 13,846 shares worth $252K. The position accounts for 0.21% of the portfolio, ranked #95.
Larry Mathis Financial Planning first reported a position in TAK in Q4 2025 and has held it in 4 quarters since. The position peaked at $263K in Q1 2026. 396 funds tracked by Wall St. Rank hold TAK as of Q3 2026.
- Larry Mathis Financial Planning held 13,846 shares of Takeda Pharmaceutical worth $252K as of Q3 2026.
- Larry Mathis Financial Planning sold 787 Takeda Pharmaceutical shares in Q3 2026, an estimated $13.9K.
- Takeda Pharmaceutical made up 0.21% of Larry Mathis Financial Planning's portfolio in Q3 2026, its #95 holding.
- Larry Mathis Financial Planning first reported a position in Takeda Pharmaceutical in Q4 2025 and has held it in 4 quarters since.
- Larry Mathis Financial Planning's Takeda Pharmaceutical position peaked at $263K in Q1 2026.
- 396 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2026.
Based on Larry Mathis Financial Planning's 13F filing for Q3 2026, filed 26 Oct 2026.